News Releases

June 12 , 2008

ITI Names Jeffrey Edelson, MD, Executive Vice President, R&D and Chief Medical Officer. VIEW PDF


November 9 , 2007

ITI Names Vice Presidents of Pharmaceutical Development and Commercial Development. VIEW PDF


April 4 , 2007

ITI Appoints Pharmaceutical Industry Veteran, Peter F. Young, as President and Chief Executive Officer. VIEW PDF


August 15 , 2006

ITI Closes $39.1 Million Series A Venture Financing; Company to Advance Clinical Programs in Areas of Pain Management and Central Nervous System Conditions. VIEW PDF


July 25, 2006

New ITI Study Shows Potential of Intranasal Midazolam as an Effective, Noninvasive Sedative. VIEW PDF